Recent and Upcoming Drug Therapies for Pediatric Heart Failure
Pediatric heart failure (HF) is an important clinical condition with high morbidity, mortality, and costs. Due to the heterogeneity in clinical presentation and etiologies, the development of therapeutic strategies is more challenging in children than adults. Most guidelines recommending drug therap...
Guardado en:
Autores principales: | Karla L. Loss, Robert E. Shaddy, Paul F. Kantor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53b1d27df00c43e6acbd03d5d6a1d915 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
por: Amy Hyein Kim, et al.
Publicado: (2022) -
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
por: Domingo Pascual-Figal, et al.
Publicado: (2021) -
Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
por: M. O.E. Irhuma, et al.
Publicado: (2016) -
Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
por: Marat Fudim, et al.
Publicado: (2021) -
A study of association between heart failure with preserved ejection fraction with hypertension and diabetes mellitus
por: Swapan Sarkar, et al.
Publicado: (2021)